Glass Bottles and Vials for Vaccines and Pharmaceutical Market Size, Share & Trends Analysis Report By Product Type (Less Than 30ml, Between 30ml-80ml, More than 80 ml), By Crop Type, By Application, By End-User, By Region, And By Segment Forecasts, 2024-2031
The Glass Bottles and Vials for Vaccines and Pharmaceutical Market is Expected to grow at a 7.7% CAGR during the forecast period of 2024-2031.
Key Industry Insights & Findings from the Report:
- The rising demand for vaccines and pharmaceutical products worldwide is a major driver for the market.
- The increasing investment in the pharmaceutical industry, along with rising vaccine production and government initiatives, are projected to propel the expansion of the vaccine vials market.
- North America dominated the market and accounted for a global revenue share in 2023.
- A key challenge for the glass bottles and vials for vaccines and pharmaceutical market is the rising cost of overall packaging, as highlighted in the search results.
A vial is a small glass or plastic container that stores medication in powders, liquids, and capsules (also referred to as a flacon or phial). The demand for glass bottles and vials has increased due to end users using glass vials more frequently than conventional vials. Since they make recycling simple, they are also eco-friendly. Glass bottles and vials allow producers to lower production costs while providing consumers with items of higher quality. As the demand for pharmaceutical packaging surges, it opens up the potential for marketers to sell the vaccine and pharmaceutical glass bottles and vials. As chances for marketers are created by a rise in demand for pharmaceutical packaging, the glass bottles and vials for vaccines and the pharmaceutical industry are rising. Leading industry players are spending money to improve their market position. A vial maker, SCHOTT AG, recently invested US $333 million in pharmaceutical packaging to grow its glass tubing business. Global market companies are attempting to increase their product offerings and global presence in this industry.
Since the COVID-19 pandemic, the demand for glass bottles and vials used for pharmaceutical and vaccination products has grown exponentially. Following the COVID-19 vaccines' approval, vaccination campaigns have been launched in numerous nations. Due to the enormous demand for glass bottles and vials for vaccine packaging from vaccine makers, the market is expanding. In addition, the market for glass bottles and vials for pharmaceuticals and vaccines will be significantly constrained by the rising cost of the overall packaging.
Competitive Landscape
Some major key players in the Glass Bottles and Vials for Vaccines and Pharmaceutical Market:
- SCHOTT AG,
- Thermo Fisher Scientific,
- ZHENGCHUAN ICP,
- Cang Zhou Four-star Glass Co., Ltd,
- Stevanato Group PIVA,
- Gerresheimer AG,
- SGD Pharma,
- Qorpak,
- Corning Incorporated
- SM PACK.
Market Segmentation:
The Glass Bottles and Vials for Vaccines and Pharmaceutical market is segmented based on application and end-user. Based on application, the market is segmented into vaccines and general medicine. Based on end-user, the glass bottles and vials for vaccines and pharmaceutical is segmented into hospital, drug manufacturers, diagnostic centers and others.
Based On Application, The Vaccines Segment Is Accounted As A Major Contributor In The Glass Bottles And Vials For Vaccines And Pharmaceutical Market
Based on application, the market is segmented into vaccines and general medicine. The vaccine segment dominated the market. Vaccine vials are used in pharmaceutical packaging. The vaccination vial is a compact cylindrical container that can be utilized in industries such as pharmaceutical, medical, environmental, and lab testing. There are several varieties of vaccine vials available, including single dosage and multi-dose vials. Increased investment in glass vaccine vials, particularly in the pharmaceutical industry, increased vaccine production, and rising government initiatives in the biochemical industry are key drivers projected to fuel the growth of the vaccine vials market.
The Hospital Segment Witnessed Growth At A Rapid Rate
Based on end-user, the glass bottles and vials for vaccines and pharmaceutical is segmented into hospital, drug manufacturers, diagnostic centers and others. The hospital category dominated the market. The need for glass bottles and vials has increased due to their expanding use by hospitals. In hospitals, glass bottles and vials are frequently used to store medications and samples. Over the past ten years, glass bottles and vials have grown in popularity in hospitals because they are non-reactive, have a long shelf life, and are contamination-free.
In The Region, The North America Glass Bottles And Vials For Vaccines And Pharmaceutical Market Holds A Significant Revenue Share.
The North America Glass Bottles and Vials for Vaccines and Pharmaceutical market is expected to register the highest market share in revenue in the near future. Pharmaceutical spending in developing nations is expected to rise in the coming years. With innovative products driving the rise, the United States is projected to be a prominent driver and the region's most important market for expanding the pharmaceutical sector. This expansion is predicted to be aided by an increase in generics in the region, which are expected to maintain high volume and sales demand. In addition, Asia Pacific is projected to grow rapidly in the global Glass Bottles and Vials for Vaccines and Pharmaceutical market. Chronic disease incidence increased healthcare expertise, and rising income levels will help Asia Pacific emerging markets expand. Governments in the Asia Pacific region are expanding their private and public healthcare coverage due to increased knowledge. Government actions in emerging countries to encourage low-cost generic drugs and lower healthcare costs are projected to raise the volume of pharmaceutical products, encouraging the region's market expansion even further.
Recent Developments:
- In March 2021, SCHOTT has reached a noteworthy achievement in the battle against COVID-19 by effectively supplying vials for 1 billion vaccination doses. Vials were allocated to programs globally, with a specific focus on the US, Europe, and China. Approximately 90 percent of authorized vaccines utilized SCHOTT containers.
Glass Bottles and Vials for Vaccines and Pharmaceutical Market Report Scope
| Report Attribute | Specifications |
| Growth rate CAGR | CAGR of 7.7% from 2024 to 2031 |
| Quantitative units | Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments covered | Product Type, Crop Type, Application, End-User |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | SCHOTT AG, Thermo Fisher Scientific, ZHENGCHUAN ICP, Cang Zhou Four-star Glass Co., Ltd, Stevanato Group PIVA, Gerresheimer AG, SGD Pharma, Qorpak, Corning Incorporated and SM PACK. |
| Customization scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and available payment methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation Of the Glass Bottles and Vials for Vaccines and Pharmaceutical Market
By Product Type-
- Less Than 30ml
- Between 30ml-80ml
- More than 80 ml
By Application-
- Vaccines
- General Medicine
By End-User
- Hospital
- Drug manufacturers
- Diagnostic Centers
- Others
By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
The Glass Bottles and Vials for Vaccines and Pharmaceutical Market is Expected to grow at a 7.7% CAGR during the forecast period of 2024-2031.
SCHOTT AG, Thermo Fisher Scientific, ZHENGCHUAN ICP, Cang Zhou Four-star Glass Co., Ltd, Stevanato Group PIVA, Gerresheimer AG, SGD Pharma, Qorpak, Co